Ankita Sanjali

Ankita Sanjali

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4596038
武田薬品工業株式会社
person_outline Ankita Sanjali's MOST POPULAR ARTICLES
1-) Somatic hypermutation and framework mutations of variable region contribute to anti-zika virus-specific monoclonal antibody binding and function Journal of Virology 96 (11), e00071-22, 2022
2-) Development of a novel assay to assess the avidity of dengue virus-specific antibodies elicited in response to a tetravalent dengue vaccine,The Journal of Infectious Diseases 225 (9), 1533-1544, 2022 -
3-) Somatic hypermutation and framework mutations of variable region contribute to anti-zika virus-specific monoclonal antibody binding and function,Journal of Virology 96 (11), e00071-22, 2022 -
4-) CSI-GEP: A GPU-based unsupervised machine learning approach for recovering gene expression programs in atlas-scale single-cell RNA-seq dataX Liu, RH Chapple, D Bennett, WC Wright, A Sanjali, E Culp, Y Zhang, ...Cell Genomics 5 (1), 2025
5-) EFFECT OF COMPUTATIONALLY SYNTHESIZED PROBABLE DRUGS ON BETA TOXIN OF CLOSTRIDIUM PERFRINGENSP DR, G Akshatha, A Sanjali, D Madhuri, HL PriyankaMSR Journal of Sciences, 77, 0